Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

OBJECTIVE Screening allows for early management of pulmonary arterial hypertension (PAH), a severe complication of systemic sclerosis (SSc). Since no consensus has been reached on the method and criteria for optimal screening, we sought to develop an algorithm based on symptoms, Doppler echocardiography, and right heart catheterization (RHC) for application to a nationwide multicenter SSc population in France. METHODS This prospective study was conducted from September 2002 to July 2003 by experts at 21 SSc centers. At each center, SSc patients without severe pulmonary function abnormalities underwent Doppler echocardiography by an experienced cardiologist. Patients with a peak velocity of tricuspid regurgitation (VTR) of >3 meters/second or 2.5-3 meters/second with unexplained dyspnea were asked to undergo RHC to confirm PAH according to international guidelines. RESULTS Of the 599 patients analyzed, 29 had known PAH and 33 had suspected PAH, based on Doppler echocardiography, and underwent RHC. Of these 33, 18 were found to have PAH, 3 had left ventricular dysfunction, and 12 had no PAH. Newly diagnosed cases of PAH were of mild severity (mean +/- SD pulmonary artery pressure [mPAP] 30 +/- 9 mm Hg, mean +/- SD total pulmonary resistance [TPR] 524 +/- 382 dynes x second/cm(5)). Hemodynamic findings in patients with known PAH were mPAP 49 +/- 17 mm Hg and TPR 1,007 +/- 615 dynes x second/cm(5). The estimate of PAH prevalence was 7.85% (95% confidence interval 5.70-10.00). CONCLUSION This screening algorithm, based on dyspnea, Doppler echocardiographic evaluation of VTR, and RHC, enabled early detection of PAH at a mild stage. Whether mild PAH will evolve to severe PAH in reported cases and whether this early diagnosis translates into improved prognosis for patients with mild PAH will be evaluated in the ongoing 3-year followup of this cohort.

[1]  M. Humbert,et al.  Treatment of pulmonary arterial hypertension. , 2004, The New England journal of medicine.

[2]  L. Mouthon,et al.  Prevalence of systemic sclerosis in a French multi-ethnic county. , 2004, Rheumatology.

[3]  K. Peterson,et al.  Cardiac catheterization techniques in pulmonary hypertension. , 2004, Cardiology clinics.

[4]  D. Mccrory,et al.  Medical Therapy For Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines , 2004 .

[5]  D. Mccrory,et al.  Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines. , 2004, Chest.

[6]  D. Mccrory,et al.  Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.

[7]  A. Torbicki,et al.  Diagnosis and differential assessment of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[8]  W. Seeger,et al.  Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[9]  R. D. du Bois,et al.  Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. , 2004, Rheumatology.

[10]  C. Denton,et al.  Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach , 2003, Annals of the rheumatic diseases.

[11]  T. Medsger,et al.  Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. , 2003, Arthritis and rheumatism.

[12]  S. Kimmel,et al.  Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. , 2003, Chest.

[13]  O. Sanchez,et al.  Hypertension artérielle pulmonaire associée aux connectivites , 2002 .

[14]  R. Speich,et al.  Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.

[15]  Arthur E. Weyman,et al.  Clinical Correlates and Reference Intervals for Pulmonary Artery Systolic Pressure Among Echocardiographically Normal Subjects , 2001, Circulation.

[16]  J. Roelandt,et al.  Transseptal left heart catheterisation guided by intracardiac echocardiography , 2001, Heart.

[17]  A. Chaouat,et al.  "Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. , 2001, American journal of respiratory and critical care medicine.

[18]  R. Hall Self portrait of patient with severe cardiac pain awaiting surgery , 2001, Heart.

[19]  C. Denton,et al.  Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. , 2001, Rheumatology.

[20]  D. Launay,et al.  Dépistage de l'hypertension artérielle pulmonaire au cours de la sclérodermie systémique : étude d'une cohorte de 67 patients , 2000 .

[21]  T. Tanigawa,et al.  Clinical Evaluation of Pulmonary Hypertension in Systemic Sclerosis and Related Disorders: A Doppler Echocardiographic Study of 135 Japanese Patients , 1997 .

[22]  M. Tischler,et al.  Prevalence of pulmonary hypertension in limited and diffuse scleroderma. , 1996, Chest.

[23]  J. Seward,et al.  Frequency of Doppler measurable pulmonary artery pressures. , 1996, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[24]  M Abu-Shakra,et al.  Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. , 1996, British journal of rheumatology.

[25]  A. Silman,et al.  Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. , 1993, The Journal of rheumatology.

[26]  S. Shinohara,et al.  Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes. , 1992, Japanese circulation journal.

[27]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[28]  A. Van Tosh,et al.  Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. , 1985, Journal of the American College of Cardiology.

[29]  D. Furst,et al.  Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. , 1983, The American journal of medicine.

[30]  A. Masi Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[31]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.